Evidence map›Paper›PMID 35533820›Full record

SynthesisThe Journal of arthroplasty2022

Making a Joint Decision Regarding the Timing of Surgery for Elective Arthroplasty Surgery After Being Infected With COVID-19: A Systematic Review.

Irfan A Khan, Musa B Zaid, Peter A Gold, Matthew S Austin, Javad Parvizi, Nicholas A Bedard, David S Jevsevar, Charles P Hannon, Yale A Fillingham, AAHKS EBM Committee

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in The Journal of arthroplasty, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Irfan A KhanRothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania.
Musa B ZaidRothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania.
Peter A GoldRothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania.
Matthew S AustinRothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania.
Javad ParviziRothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania.
Nicholas A BedardDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.
David S JevsevarDepartment of Orthopaedics, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Charles P HannonDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.
Yale A FillinghamRothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania.
AAHKS EBM Committee
Thomas Jefferson University · USMayo Clinic · USDartmouth–Hitchcock Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Coronavirus Disease 2019 (COVID-19) pandemic has caused a substantial number of patients to have their elective arthroplasty surgeries rescheduled. While it is established that patients with COVID-19 who are undergoing surgery have a significantly higher risk of experiencing postoperative complications and mortality, it is not well-known at what time after testing positive the risk of postoperative complications or mortality returns to normal.

methodsPubMed (MEDLINE), Excerpta Medica dataBASE, and professional society websites were systematically reviewed on March 7, 2022 to identify studies and guidelines on the optimal timeframe to reschedule patients for elective surgery after preoperatively testing positive for COVID-19. Outcomes included postoperative complications such as mortality, pneumonia, acute respiratory distress syndrome, septic shock, and pulmonary embolism.

resultsA total of 14 studies and professional society guidelines met the inclusion criteria for this systematic review. Patients with asymptomatic COVID-19 should be rescheduled 4-8 weeks after testing positive (as long as they do not develop symptoms in the interim), patients with mild/moderate COVID-19 should be rescheduled 6-8 weeks after testing positive (with complete resolution of symptoms), and patients with severe/critical COVID-19 should be rescheduled at a minimum of 12 weeks after hospital discharge (with complete resolution of symptoms).

conclusionsGiven the negative association between preoperative COVID-19 and postoperative complications, patients should have elective arthroplasty surgery rescheduled at differing timeframes based on their symptoms. In addition, a multidisciplinary and patient-centered approach to rescheduling patients is recommended. Further study is needed to examine the impact of novel COVID-19 variants and vaccination on timeframes for rescheduling surgery.

Indexed as

COVID-19ArthroplastyElective Surgical ProceduresHumansPostoperative ComplicationsSARS-CoV-2arthroplastyCOVID-19electivereschedulingsafetysurgery

Identifiers

PMID35533820
PMCPMC9074381
OpenAlexW4229076905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.